| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9978725 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 8 Pages |
Abstract
The results presented here show for the first time that immunohistochemical expression of estrogen receptor β can be used as a prognostic indicator in patients with surgically resected stage II and III non-small cell lung cancers. These observations might offer a possibility for hormonal therapy in patients with lung cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chen-Tu MD, Yih-Leong MD, Jin-Yuan MD, PhD, Yung-Chie MD, PhD,